Financial results that exceed market expectations typically lead to a positive short-term reaction in a company's stock price. Given that Moderna's Q1 results were better than anticipated, this positive outcome is reflected in the stock's performance. Investors and analysts often view earnings reports as a key indicator of a company's health and future prospects, making such announcements critical for stock valuation.